Listen now
Key takeaways
- The EU Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) have created significant bottlenecks, making the US FDA approval process a more predictable initial market for many MedTech companies.
- Artificial Intelligence serves as an efficiency tool for experienced software engineers but does not substitute for human expertise in MedTech development.
- Over-reliance on AI without expert human oversight can lead to inefficiencies and flaws in code, emphasizing the need for a seasoned developer's guidance and validation.
- Successful MedTech product development requires a collaborative team of specialized experts in regulatory affairs, software engineering, and cybersecurity.
- Addressing regulatory compliance and cybersecurity early in the development cycle is crucial to avoid costly delays and rework.
- Mislabeling simple algorithms as AI to attract investors can introduce unnecessary regulatory scrutiny and complexity for MedTech products.
- Specialized knowledge in medical software development and regulatory affairs is essential due to the nuanced requirements of the MedTech industry.
Medical software is still underestimated by teams that think generic engineering habits will carry over cleanly into a regulated environment. They do not. The work gets harder when requirements, traceability, security, testing discipline, and approval timelines all collide.
A stronger strategy starts earlier, uses specialists sooner, and avoids making AI or code velocity the headline when architectural quality and compliance readiness are what determine whether a product can truly ship.
Notable quotes
“The EU was considered easier for market entry previously. Now, with the new regulations, it takes anywhere from 9-13 months, sometimes even two years, to get approval.”
“AI is a powerful tool, like a power drill for a carpenter. It makes you more efficient, but it does not make a novice into a carpenter.”
“If you rely too heavily on AI without expert oversight, it can lead you into the deep forest, creating inefficient or flawed code that costs a lot to fix.”
“Bringing a product to market successfully takes a village.”
Frequently asked questions
More episodes
Keep listening
-
Episode 75
What MedTech Can Learn from the Casino Industry with Melissa Aarskaug
With Melissa Aarskaug
-
Episode 74
The Future of Cardio-Oncology Wearables with Ryan Neely
With Ryan Neely
-
Episode 73
Navigating U.S. Market Entry for MedTech Developers with JJ Amell
With JJ Amell
-
Episode 72
The Psychology of Medical Device Security Awareness with Shahbaz Ahmed
With Shahbaz Ahmed